2142-2143 / 2351
Salivary duct carcinoma
•
Adenocarcinoma/salivary duct: rare
•
Higher prevalence in men, > 50 years old
•
Mainly in parotid gland
•
Agressive with median survival: 3 years
•
Histologically resemblance to invasive ductal
carcinoma
•
ER and PR rarely positive
•
Androgen receptor present in 30-40%
Salivary gland: metastatic disease